A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan
· Delayed Price · Currency is TWD 81.50
-2.50 (-2.98%)
At close: Mar 9, 2026
A Plus Biotechnology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cash & Equivalents | 488.92 | 360.97 | 319.07 | 305.09 | 289.31 |
| Short-Term Investments | 104 | 30 | - | 1 | 1 |
| Cash & Short-Term Investments | 592.92 | 390.97 | 319.07 | 306.09 | 290.31 |
| Cash Growth | 73.56% | 22.54% | 4.24% | 5.44% | - |
| Accounts Receivable | 184.75 | 184.53 | 141.67 | 133.31 | 133.75 |
| Other Receivables | - | - | 2.11 | 3.07 | 1.96 |
| Receivables | 184.75 | 184.53 | 143.77 | 136.38 | 135.71 |
| Inventory | 333.07 | 286.94 | 283.76 | 300.67 | 277.13 |
| Prepaid Expenses | 47.52 | 29.26 | 17.49 | 16.06 | 9.39 |
| Other Current Assets | 4.1 | 5.15 | 5.49 | 2.07 | 0 |
| Total Current Assets | 1,162 | 896.85 | 769.58 | 761.27 | 712.54 |
| Property, Plant & Equipment | 246.6 | 251.91 | 259.02 | 233.38 | 18.16 |
| Other Intangible Assets | 4.69 | 6.51 | 8.24 | 178.16 | 176.75 |
| Long-Term Deferred Tax Assets | 12.61 | 12.66 | 31.24 | 9.8 | 11.6 |
| Other Long-Term Assets | 16.65 | 9.38 | 3.26 | 23.24 | 11.15 |
| Total Assets | 1,529 | 1,177 | 1,071 | 1,206 | 930.2 |
| Accounts Payable | 52 | 39.4 | 28.9 | 39.81 | 26.26 |
| Accrued Expenses | 61.93 | 72.48 | 43.69 | - | - |
| Short-Term Debt | - | - | - | 37.8 | 31.93 |
| Current Portion of Long-Term Debt | 4.8 | 4.72 | 4.78 | - | - |
| Current Portion of Leases | 8.94 | 8.07 | 8.64 | 9.78 | 3.76 |
| Current Income Taxes Payable | 19.41 | 2.95 | 19.56 | 7.97 | 3.83 |
| Current Unearned Revenue | 3.1 | 0.91 | 1.49 | 0.9 | 2.58 |
| Other Current Liabilities | 37.52 | 34.77 | 35.77 | 107.08 | 85.27 |
| Total Current Liabilities | 187.69 | 163.31 | 142.83 | 203.35 | 153.62 |
| Long-Term Debt | 83.59 | 87.2 | 93.83 | 153.98 | - |
| Long-Term Leases | 2.16 | 6.82 | 5.79 | 3.31 | 2.99 |
| Long-Term Deferred Tax Liabilities | - | 0.01 | - | 0.11 | 0.38 |
| Other Long-Term Liabilities | 0.54 | 0.94 | 0.93 | 1.16 | 1 |
| Total Liabilities | 273.98 | 258.27 | 243.38 | 361.91 | 157.99 |
| Common Stock | 345.71 | 304.71 | 304.71 | 304.71 | 286.49 |
| Additional Paid-In Capital | 600.25 | 307.68 | 360.01 | 358.55 | 320.4 |
| Retained Earnings | 308.56 | 300.05 | 177.04 | 179 | 160.38 |
| Treasury Stock | - | - | -14.15 | - | - |
| Comprehensive Income & Other | -2.35 | 6.61 | 0.35 | 1.68 | 1.1 |
| Total Common Equity | 1,252 | 919.05 | 827.94 | 843.94 | 768.37 |
| Minority Interest | 2.73 | - | - | - | 3.84 |
| Shareholders' Equity | 1,255 | 919.05 | 827.94 | 843.94 | 772.21 |
| Total Liabilities & Equity | 1,529 | 1,177 | 1,071 | 1,206 | 930.2 |
| Total Debt | 99.48 | 106.81 | 113.03 | 204.87 | 38.68 |
| Net Cash (Debt) | 493.44 | 284.16 | 206.03 | 101.22 | 251.64 |
| Net Cash Growth | 106.25% | 37.92% | 103.55% | -59.77% | - |
| Net Cash Per Share | 15.48 | 9.36 | 6.81 | 3.50 | 8.79 |
| Filing Date Shares Outstanding | 34.57 | 30.47 | 30.18 | 28.64 | 28.62 |
| Total Common Shares Outstanding | 34.57 | 30.47 | 30.18 | 28.64 | 28.62 |
| Working Capital | 974.67 | 733.54 | 626.75 | 557.92 | 558.92 |
| Book Value Per Share | 36.22 | 30.16 | 27.43 | 29.46 | 26.85 |
| Tangible Book Value | 1,247 | 912.54 | 819.7 | 665.77 | 591.62 |
| Tangible Book Value Per Share | 36.08 | 29.95 | 27.16 | 23.24 | 20.67 |
| Land | 117.34 | 117.34 | 117.34 | - | - |
| Buildings | 116.27 | 115.92 | 103.55 | - | - |
| Machinery | 33.39 | 35.15 | 46.84 | - | - |
| Construction In Progress | 0.45 | 0.21 | 13.48 | - | - |
| Leasehold Improvements | 10.67 | 5.19 | 5.62 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.